Accessibility Menu
Personalis logo

Personalis(NASDAQ) PSNL

Market Cap$1.27BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-58%
5 Year-44%
1 Year+110%
1 Month-15%
$11.75
-1.14%
-0.13Today
Personalis last closing stock price
MetricPriceDate
Last closeUSD 11.732026-07-29
Personalis stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.93%USD 12.472026-07-22
1 month-14.69%USD 13.752026-06-29
3 month+112.5%USD 5.522026-04-30
Year to date+47.36%USD 7.962025-12-31
1 year+110.22%USD 5.582025-07-29
3 year+414.47%USD 2.282023-07-28
5 year-44.12%USD 20.992021-07-30
Since inception-58.3%USD 28.492019-06-20

Personalis Financials at a Glance

Market Cap

$1.27BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$64.52M

Net Income (TTM)

-$95.55M

EPS (TTM)

-$1.02

P/E Ratio

-11.68

Dividend

$0.00

Beta (Volatility)

2.32 (High)

Price

$11.75

Volume

2,064,963.17

Open

$11.86

Previous Close

$11.73

Daily Range

$11.52 - $12.23

52-Week Range

$3.84 - $16.39

Estimated Earnings Date

Aug 4, 2026

PSNL News

SellAlert-Red.png

Personalis CEO Sells 100,000 Company Shares Worth $1.1 Million. What Does That Mean for Investors?

Robert IzquierdoJun 4, 2026
Foolcom-Featured.png

Personalis (PSNL) Q2 Revenue Falls 24%

Motley Fool Markets TeamAug 6, 2025
smart-doctor-contemplating-your-question-getty

Cathie Wood Goes Dumpster Diving: 3 Beaten Down Stocks She Just Bought

Cory RenauerSep 9, 2021
GettyImages-1138937146

Why Personalis Stock Dropped Today

Prosper Junior BakinyJan 27, 2021
GettyImages-200398520-001

If You Invested $10,000 in Personalis in the Coronavirus Crash, This Is How Much You'd Have Now

Taylor CarmichaelJan 23, 2021
026 question mark on wooden table

Personalis Turns to Liquid Biopsies for Growth. Will It Work?

Maxx ChatskoAug 14, 2020
multiple lines down

Here's Why Personalis Fell as Much as 13.8% Today

Maxx ChatskoAug 12, 2020
564 competition

2 Top Small-Cap Stocks to Buy in December

Maxx ChatskoDec 10, 2019
Page 1

PSNL: Motley Fool Moneyball Superscore

57

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Personalis

Personalis, Inc. operates at the forefront of genomics and precision medicine, focusing on advanced genomic sequencing solutions. It aims to transform healthcare by improving cancer diagnosis and treatment through its innovative technology.

Products and Services

NeXT Platform: Provides comprehensive genomic sequencing for detailed molecular profiling.

Cancer Genomics Solutions: Implements genetic sequencing to enhance cancer diagnosis and personalized treatment.

Population Genomics: Delivers genomic data solutions for large-scale population health management.

What Makes Personalis, Inc. Special

Personalis, Inc. distinguishes itself through its proprietary NeXT Platform, which enables highly detailed molecular profiling. This platform offers a competitive advantage by improving cancer diagnostics and facilitating personalized medicine approaches, setting it apart in the genomics industry.

Five Things You Need to Know

Personalis operates primarily in the fields of oncology and population genomics.

The company is positioned at the intersection of genomics and precision medicine.

Its technology aids in creating personalized, data-driven healthcare solutions.

Personalis collaborates with leading biopharmaceutical companies and research institutions.

The leadership team emphasizes innovation and strategic growth, underpinning future product development.

AI Generated • Apr 16, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

260

CEO

Christopher M. Hall, MBA

Website

www.personalis.com

Headquarters

Fremont, CA 94025, US

PSNL Financials

Key Financial Metrics (TTM)

Gross Margin

13.72%

Operating Margin

-158.91%

Net Income Margin

-148.11%

Return on Equity

-43.52%

Return on Capital

-29.24%

Return on Assets

-29.36%

Earnings Yield

-8.56%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.27BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

106.75M

Volume

2.06M

Avg. Volume

3.93M

Financials (TTM)

Gross Profit

$8.85M

Operating Income

-$102.52M

EBITDA

-$85.53M

Operating Cash Flow

-$79.46M

Capital Expenditure

-$5.19M

Free Cash Flow

-$84.65M

Cash & ST Invst.

$233.22M

Total Debt

$38.78M

Personalis Performance Analysis

Personalis annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 65,047,000-23.9%
20232023-12-31USD 73,481,00013.0%
20242024-12-31USD 84,614,00015.2%
20252025-12-31USD 69,648,000-17.7%
Personalis sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-16.5%
Q32025-09-30-15.7%
Q42025-12-3119.7%
Q12026-03-31-10.8%
Personalis annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -2.4866.8%
20232023-12-31USD -2.25-9.3%
20242024-12-31USD -1.37-39.0%
20252025-12-31USD -0.91-33.6%
Personalis sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-27.8%
Q32025-09-30-4.3%
Q42025-12-31-8.3%
Q12026-03-31-11.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$15.47M

-24.9%

Gross Profit

$281.00K

-96.1%

Gross Margin

1.82%

N/A

Market Cap

$1.27BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$4.88M

N/A

Employees

260

N/A

Net Income

-$30.03M

-90.7%

EBITDA

-$27.60M

-110.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$233.22M

+25.6%

Total Debt

$38.78M

-12.7%

Accounts Receivable

$13.02M

+18.7%

Inventory

$6.93M

+64.5%

Long Term Debt

$31.02M

-9.1%

Short Term Debt

$7.76M

-24.7%

Return on Assets

-29.36%

N/A

Return on Invested Capital

-35.80%

N/A

Free Cash Flow

-$25.67M

-25.4%

Operating Cash Flow

-$22.48M

-25.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GERNGeron Corporation
$1.40-3.45%
CSTLCastle Biosciences, Inc.
$24.46+2.39%
MRVIMaravai LifeSciences Holdings, Inc.
$6.59-3.94%
CDNACareDx, Inc
$35.41-0.95%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$15.25-0.09%
INTCIntel
$81.88-0.05%
NVDANvidia
$190.01-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About PSNL

What is the current price of Personalis?

Personalis is trading at $11.73 per share.

What is the 52-week range for Personalis?

Over the past 52 weeks, Personalis has traded between $3.84 and $16.39.

How much debt does Personalis have?

As of the most recent reporting period, Personalis reported total debt of $38.78M.

How much cash does Personalis have on hand?

Personalis reported $73.59M in cash and cash equivalents in its most recent financial results.

What is Personalis’s dividend yield?

Personalis does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services